Skip to main content

Table 1 Characteristics in the trans-perineal (TP) and trans-rectal prostate (TR) biopsy

From: Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study

  TP(n = 130) TR(n = 108) P value
Age (years) 66.6 ± 8.81 67.1 ± 8.45 0.708b
Median PSA level (ng/ml)
[25–75%]
9.3[6.3–20.3] 10.9[7.8–17] 0.099a
 PSA < 4 ng/ml 3/130 7/108 0.11c
 10 > PSA > 4 ng/ml 62/130 52/108 0.944c
 PSA > 10 ng/ml 66/130 49/108 0.407c
DRE positive 49/130 50/108 0.18c
Median Biopsy core number [25–75%] 10[10–10] 10[10–10] 0.574a
Prostate Volume
[25–75%]
32.5[27–41] 35[29–47] 0.015a
Prophylaxis abx use 0/130 Baktar: 28/108
Ceftibuten:25/108
Ciprofloxacin:5/108
Levofloxacin:50/108
<0.001c
Anesthesia procedure IVG: 32/130
LA + PPNB: 98/130
Lidocaine Jelly lubrication  
  1. TP trans-perineal prostate biopsy, TR trans-rectal prostate biopsy, PSA prostate specific antigen, DRE digital rectal examination, a: Mann-Whitney test. b: Student T test. c: Chi-Square test